Literature DB >> 2649377

Tumor grade as a prognostic factor in primary breast cancer.

G Contesso1, G S Jotti, G Bonadonna.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2649377     DOI： 10.1016/0277-5379(89)90251-4

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  10 in total

1.  The prognostic effect of histological tumor grade in node-negative breast cancer patients.

Authors:  M Schumacher; C Schmoor; W Sauerbrei; A Schauer; L Ummenhofer; W Gatzemeier; H Rauschecker
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma.

Authors:  Rimma Danielsson; Alejandro Sánchez-Crespo; Anna Pegerfalk; Hanna Grabowska; Stig A Larsson; Beata Boné; Peter Aspelin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-04       Impact factor: 9.236

3.  Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast.

Authors:  C M Chan; F S Baratta; L Ozzello; R L Ceriani
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients.

Authors:  C Wiltschke; I Kindas-Muegge; A Steininger; A Reiner; G Reiner; P N Preis
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.

Authors:  M A Levesque; E P Diamandis; H Yu; D J Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer.

Authors:  P Kronqvist; T Kuopio; P Jalava; Y Collan
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

7.  Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.

Authors:  M A Levesque; G M Clark; H Yu; E P Diamandis
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

8.  Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Authors:  C Wiltschke; M Krainer; A C Budinsky; A Berger; C Müller; R Zeillinger; P Speiser; E Kubista; M Eibl; C C Zielinski
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

9.  Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response.

Authors:  Gina Marrão; Mohammed Habib; Artur Paiva; Dominique Bicout; Catherine Fallecker; Sofia Franco; Samira Fafi-Kremer; Teresa Simões da Silva; Patrice Morand; Carlos Freire de Oliveira; Emmanuel Drouet
Journal:  BMC Cancer       Date:  2014-09-11       Impact factor: 4.430

10.  Analysis of cytosolic phosphoethanolamine and ethanolamine and their correlation with prognostic factors in breast cancer.

Authors:  T Kano-Sueoka; T Watanabe; T Miya; H Kasai
Journal:  Jpn J Cancer Res       Date:  1991-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.